Innovations for Next-Generation Antibody-Drug Conjugates
Antibody-drug conjugates (ADCs) stand at the verge of a transformation. Scores of clinical programs have yielded only a few regulatory approvals, but a wave of technological innovation now empowers us to overcome past technical challenges. This volume focuses on the next generation of ADCs and the i...
Corporate Author: | SpringerLink (Online service) |
---|---|
Other Authors: | Damelin, Marc (Editor, http://id.loc.gov/vocabulary/relators/edt) |
Format: | Electronic eBook |
Language: | English |
Published: |
Cham :
Springer International Publishing : Imprint: Humana,
2018.
|
Edition: | 1st ed. 2018. |
Series: | Cancer Drug Discovery and Development,
|
Subjects: | |
Online Access: | Full Text via HEAL-Link |
Similar Items
-
Resistance of Targeted Therapies Excluding Antibodies for Lymphomas
Published: (2018) -
Targeted Therapies for Lung Cancer
Published: (2019) -
Current Applications for Overcoming Resistance to Targeted Therapies
Published: (2019) -
Estrogen Receptor and Breast Cancer Celebrating the 60th Anniversary of the Discovery of ER /
Published: (2019) -
Recent Trends in Cancer Biology: Spotlight on Signaling Cascades and microRNAs Cell Signaling Pathways and microRNAs in Cancer Biology /
Published: (2018)